These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 7006107)
1. Combination of radiosensitizers and hyperthermia in tumour radiotherapy. Brückner V S Afr Med J; 1981 Jan; 59(4):116-7. PubMed ID: 7006107 [TBL] [Abstract][Full Text] [Related]
2. [Radiosensitization research in cancer therapy]. Sugahara T Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 1):405-11. PubMed ID: 3890755 [TBL] [Abstract][Full Text] [Related]
3. [Enhancement of hyperthermochemotherapy with hypoxic cell radiosensitizers]. Ohta M; Fujimoto S; Shresta RD; Kokubun M; Kobayashi K; Kiuchi S; Miyoshi T; Arimatsu N; Mori T; Okui K Gan No Rinsho; 1988 Mar; 34(3):283-7. PubMed ID: 3128668 [TBL] [Abstract][Full Text] [Related]
4. Photosensitizers and radiosensitizers in dermatology and oncology. Brückner V S Afr Med J; 1979 Sep; 56(13):528-31. PubMed ID: 550390 [TBL] [Abstract][Full Text] [Related]
5. The effect of hypoxic radiosensitizer after mild hyperthermia in C3H mammary carcinoma. Ohizumi Y; Murayama C; Maezawa H; Mori T Tokai J Exp Clin Med; 1984 Oct; 9(4):331-7. PubMed ID: 6537042 [TBL] [Abstract][Full Text] [Related]
6. Radiosensitizers: rationale and potential. Brown JM Cancer Treat Rep; 1981; 65 Suppl 2():95-102. PubMed ID: 7346152 [TBL] [Abstract][Full Text] [Related]
7. [Focus on research and results of unusual radiotherapy technics (heavy particles, hyperthermia, radiosensitizers)]. Eschwege F; Habrand JL; Lusinchi A; Cosset JM; Girinski T Ann Med Interne (Paris); 1989; 140(5):358-61. PubMed ID: 2556954 [TBL] [Abstract][Full Text] [Related]
8. The potential of using hyperthermia to eliminate radioresistant hypoxic cells. Overgaard J; Grau C; Lindegaard JC; Horsman MR Radiother Oncol; 1991; 20 Suppl 1():113-6. PubMed ID: 2020761 [TBL] [Abstract][Full Text] [Related]
10. Addition of 2-nitroimidazole radiosensitizers to cis-diamminedichloroplatinum(II) with radiation and with or without hyperthermia in the murine FSaIIC fibrosarcoma. Herman TS; Teicher BA; Holden SA; Pfeffer MR; Jones SM Cancer Res; 1990 May; 50(9):2734-40. PubMed ID: 2139359 [TBL] [Abstract][Full Text] [Related]
11. [Role of radiation biology in the standardization and optimization of radiotherapy]. Onoyama Y Gan No Rinsho; 1985 Sep; 31(12):1525-8. PubMed ID: 4079041 [TBL] [Abstract][Full Text] [Related]
12. Cytotoxicity of radiosensitizers in multicell spheroids: combination treatment with hyperthermia. Sutherland R; Macfarlane W Br J Cancer Suppl; 1978 Jun; 3():168-72. PubMed ID: 277220 [TBL] [Abstract][Full Text] [Related]
13. [Recent data on biological and clinical properties of radiosensitizers (author's transl)]. Guichard M; Malaise EP Sem Hop; 1980 Jun 8-15; 56(21-24):1094-107. PubMed ID: 6156491 [TBL] [Abstract][Full Text] [Related]
14. [Modification of the radiation effects for overcoming radiation-resistant hypoxic tumor tissue]. Moldenhauer H; Rose H; Saul G; Wolf G; Kehrberg G Radiobiol Radiother (Berl); 1983; 24(5):597-614. PubMed ID: 6316407 [No Abstract] [Full Text] [Related]
15. The use of a hypoxic cell radiosensitizer AK-2123 gave no improvement in thermoradiotherapy combined with hydralazine. Kozin SV; Hasegawa T; Kozina LV; Imamura M; Akagi K; Tanaka Y; Kagiya VT Int J Hyperthermia; 1996; 12(6):771-7. PubMed ID: 8950157 [TBL] [Abstract][Full Text] [Related]
16. The relevance of tumour pH to the treatment of malignant disease. Wike-Hooley JL; Haveman J; Reinhold HS Radiother Oncol; 1984 Dec; 2(4):343-66. PubMed ID: 6097949 [TBL] [Abstract][Full Text] [Related]
17. The role of radiosensitizing drugs in the management of cancer. Adams GE Invest Cell Pathol; 1979; 2(4):303-8. PubMed ID: 396284 [TBL] [Abstract][Full Text] [Related]
18. [A review. Current problems of experimental and clinical radiotherapy]. Merkle K Arch Geschwulstforsch; 1987; 57(1):69-79. PubMed ID: 3551869 [TBL] [Abstract][Full Text] [Related]
19. Enhancement of local tumour control by misonidazole and hyperthermia. Stone HB Br J Cancer Suppl; 1978 Jun; 3():178-83. PubMed ID: 277222 [TBL] [Abstract][Full Text] [Related]